Literature DB >> 15940764

Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.

Veena K Ranganath1, David A Elashoff, Dinesh Khanna, Grace Park, James B Peter, Harold E Paulus.   

Abstract

OBJECTIVE: To evaluate the effect of age adjustment on baseline erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) in patients with late-onset rheumatoid arthritis (LORA, age > or = 55 yrs) and younger-onset RA (YORA, age < 55 yrs) in a cohort with early, rheumatoid factor (RF) positive RA that has not received disease modifying antirheumatic drugs (DMARD).
METHODS: In an ongoing prospective cohort study of 263 patients with seropositive RA who were enrolled within 14 months of symptom onset, baseline assessments included ESR, CRP, tender and swollen joint counts, and functional status. Westergren ESR determinations were performed in the rheumatologist's office or in a local laboratory using appropriate methods. CRP were performed at the Specialty Laboratories in Santa Monica, CA, using Behring nephelometry. Percentages of patients with greater than the upper limit of normal (ULN) laboratory values using both age-unadjusted and age-adjusted ESR and CRP values were determined. The late-onset and younger-onset RA patients were compared using Wilcoxon rank-sum and chi-square tests.
RESULTS: At study entry, both the YORA and LORA patients had comparable symptom duration, disease activity scores, tender and swollen joint counts, and Health Assessment Questionnaire values. RF, CRP, and ESR were significantly higher (p < 0.05) in LORA patients. Although the percentages of patients with age-unadjusted ESR and CRP above ULN were higher in LORA patients, the percentages exceeding the age-adjusted ULN did not differ significantly between the YORA and LORA groups.
CONCLUSION: In patients with late-onset and younger-onset RA with similar disease duration and severity, the apparent discrepancy in elevation of both the baseline ESR and CRP disappears after age-adjustment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15940764

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis.

Authors:  Ashutosh Tamhane; David T Redden; Gerald McGwin; Elizabeth E Brown; Andrew O Westfall; Richard J Reynolds; Laura B Hughes; Doyt L Conn; Leigh F Callahan; Beth L Jonas; Edwin A Smith; Richard D Brasington; Larry W Moreland; S Louis Bridges
Journal:  J Rheumatol       Date:  2013-08-15       Impact factor: 4.666

2.  Obesity Impacts Swelling of Ankle and Foot Joints in Early Rheumatoid Arthritis Patients.

Authors:  Veena K Ranganath; Erin L Duffy; Vikram K Garg; Thasia Woodworth; Mihaela Taylor; Harold E Paulus; Roy D Altman; David A Elashoff
Journal:  J Clin Rheumatol       Date:  2019-04       Impact factor: 3.517

3.  Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort.

Authors:  Veena K Ranganath; Jeonglim Yoon; Dinesh Khanna; Grace S Park; Daniel E Furst; David A Elashoff; Damini Jawaheer; John T Sharp; Richard H Gold; Edward C Keystone; Harold E Paulus
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

4.  Periprosthetic joint infection in patients with inflammatory joint disease: a review of risk factors and current approaches to diagnosis and management.

Authors:  Todd A Morrison; Mark Figgie; Andy O Miller; Susan M Goodman
Journal:  HSS J       Date:  2013-07-03

5.  Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.

Authors:  William J Martin; Man Shim; Harold E Paulus; Sandeep Chaudhari; JingYuan Feng; David Elashoff; Theodore J Hahn; Veena K Ranganath
Journal:  J Clin Rheumatol       Date:  2014-09       Impact factor: 3.517

6.  Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity.

Authors:  John M Davis; Jaeyun Sung; Benjamin Hur; Vinod K Gupta; Harvey Huang; Kerry A Wright; Kenneth J Warrington; Veena Taneja
Journal:  Arthritis Res Ther       Date:  2021-06-08       Impact factor: 5.156

7.  Contrasting diagnosis performance of forced oscillation and spirometry in patients with rheumatoid arthritis and respiratory symptoms.

Authors:  Alvaro Camilo Dias Faria; Wellington Ribeiro Barbosa; Agnaldo José Lopes; Geraldo da Rocha Castelar Pinheiro; Pedro Lopes de Melo
Journal:  Clinics (Sao Paulo)       Date:  2012-09       Impact factor: 2.365

8.  How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis.

Authors:  Liseth Siemons; Peter M Ten Klooster; Harald E Vonkeman; Piet L C M van Riel; Cees A W Glas; Mart A F J van de Laar
Journal:  BMC Musculoskelet Disord       Date:  2014-11-06       Impact factor: 2.362

9.  Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis.

Authors:  Michelle J Ormseth; Cecilia P Chung; Annette M Oeser; Margery A Connelly; Tuulikki Sokka; Paolo Raggi; Joseph F Solus; James D Otvos; C Michael Stein
Journal:  Arthritis Res Ther       Date:  2015-05-09       Impact factor: 5.156

10.  Effects of intra-articular SHINBARO treatment on monosodium iodoacetate-induced osteoarthritis in rats.

Authors:  Won Kyung Kim; Hwa-Jin Chung; Yuna Pyee; Tae Jun Choi; Hyen Joo Park; Ji-Young Hong; Joon-Shik Shin; Jin Ho Lee; In-Hyuk Ha; Sang Kook Lee
Journal:  Chin Med       Date:  2016-04-11       Impact factor: 5.455

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.